Ketamine to Treat Patients With Post-comatose Disorders of Consciousness
Status:
Not yet recruiting
Trial end date:
2026-05-01
Target enrollment:
Participant gender:
Summary
The investigators will run a Randomized Clinical Trial with 30 patients with disorders of
consciousness (DoC), with intravenous subanesthetic doses of ketamine. Patients will
simultaneously undergo TMS-EEG. The piloting will be done on 3 patients, with EEG only.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Liege
Collaborators:
Centre Hospitalier Universitaire de Liege William Lennox Neurological Center UCLouvain